TEM Strengthens Radiology Portfolio With Pixel's FDA Clearance
Tempus AI secures FDA clearance for its updated Pixel cardiac imaging platform, boosting radiology precision and efficiency.
Zacks·6d ago
More News
Tempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar?
Tempus (TEM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·10d ago
TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape
Tempus AI's PurIST test secures clinical validation, helping personalize treatment choices for advanced pancreatic cancer patients.
Zacks·11d ago
TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell?
Tempus AI posts 89.6% Q2 revenue growth, raises 2025 sales outlook again, and sees positive adjusted EBITDA ahead. What is the investment outlook?
Zacks·13d ago
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?
TEM's Q2 net loss narrows sharply, driven by surging genomics revenues, higher gross profits and tighter cost controls.
Zacks·18d ago
Hims & Hers Scales Growth Through Subscriptions and Care Expansion
HIMS fuels growth through subscriptions, expanding care offerings and building proprietary health infrastructure at scale.
Zacks·26d ago
Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership
TEM accelerates its healthcare edge with Paige, Deep 6 AI, and Ambry Genetics acquisitions, expanding data, tech and clinical reach.
Zacks·27d ago
Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now?
BFLY trades at distressed levels with analyst targets signaling sharp upside, while TEM's premium valuation tempers its appeal.
Zacks·28d ago
Zacks Market Edge Highlights: ARKK, Tesla, Palantir Technologies, Robinhood Markets and Tempus
ARKK is up 27.6% in 2025, powered by bets on Tesla, Palantir, Robinhood, and Tempus-Zacks asks if it's time to buy in.
Zacks·28d ago
Tesla, Zoom, Nio, Tempus AI, Ubiquiti: Stocks Making The Biggest Moves Today
Tesla shares zoomed nearly 5% in Friday’s midday trade amid a broader surge in stocks following Powell’s speech.